Published in J Gen Virol on March 01, 1999
Signals that dictate nuclear, nucleolar, and cytoplasmic shuttling of the gamma(1)34.5 protein of herpes simplex virus type 1. J Virol (2002) 1.27
Genomic analysis of highly virulent Georgia 2007/1 isolate of African swine fever virus. Emerg Infect Dis (2011) 1.21
Replication of herpes simplex virus 1 depends on the gamma 134.5 functions that facilitate virus response to interferon and egress in the different stages of productive infection. J Virol (2004) 1.08
NoD: a Nucleolar localization sequence detector for eukaryotic and viral proteins. BMC Bioinformatics (2011) 1.06
The MyD116 African swine fever virus homologue interacts with the catalytic subunit of protein phosphatase 1 and activates its phosphatase activity. J Virol (2007) 0.98
Disruption of nuclear organization during the initial phase of African swine fever virus infection. J Virol (2011) 0.86
Deletion of virulence associated genes from attenuated African swine fever virus isolate OUR T88/3 decreases its ability to protect against challenge with virulent virus. Virology (2013) 0.84
NOA36 protein contains a highly conserved nucleolar localization signal capable of directing functional proteins to the nucleolus, in mammalian cells. PLoS One (2013) 0.77
Two African swine fever virus proteins derived from a common precursor exhibit different nucleocytoplasmic transport activities. J Virol (2004) 0.77
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol (1984) 10.98
Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A (1982) 7.81
Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group. N Engl J Med (2000) 5.98
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1985) 5.42
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature (1983) 5.25
Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation (1995) 5.06
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci U S A (1983) 4.69
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med (1998) 4.13
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. Gene (1983) 3.94
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A (2000) 3.69
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell (1995) 3.51
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell (1992) 3.36
Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature (1984) 3.21
Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (1984) 3.03
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology (1994) 2.89
The effects of metabolic inhibition on intracellular calcium and pH in isolated rat ventricular cells. J Physiol (1989) 2.86
Vaccinia virus expression vectors. J Gen Virol (1986) 2.84
Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (1979) 2.82
Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry (1999) 2.75
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med (1988) 2.73
A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology (1992) 2.67
The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology (1993) 2.66
Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J Gen Virol (1998) 2.55
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res (1990) 2.41
Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J Virol (1992) 2.35
Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science (1987) 2.24
Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol (1999) 2.24
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol (1986) 2.16
Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol (1998) 2.14
Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol (2001) 2.10
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol (2000) 2.08
Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol (1995) 2.07
EGTA purity and the buffering of calcium ions in physiological solutions. Am J Physiol (1984) 2.03
Optimized suspension culture: the rotating-wall vessel. Am J Physiol Renal Physiol (2001) 2.03
Transient inhibition of polyoma virus synthesis by Sendai virus (parainfluenza I). I. Demonstration and nature of the inhibition by inactivated virus. J Virol (1972) 2.01
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol (1996) 2.01
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A (1998) 1.97
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res (1993) 1.96
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol (1998) 1.94
Spread of prostatic cancer to bone. Urology (1983) 1.94
Seizures associated with antidepressants: a review. J Clin Psychiatry (1993) 1.91
A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J Virol (1997) 1.86
Etiology and diagnosis of pneumonia requiring ICU admission. Chest (1992) 1.86
Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J Gen Virol (1998) 1.81
K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes. Cardiovasc Res (2007) 1.76
Inducible gene expression from vaccinia virus vectors. Virology (1990) 1.76
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (1998) 1.74
Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol (1986) 1.73
An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol (1996) 1.73
Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer. Lancet (1999) 1.70
Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J Virol (1999) 1.68
Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol Today (1995) 1.68
Comparative risks and costs of male and female sterilization. Am J Public Health (1985) 1.65
Potentiometric measurements of stoichiometric and apparent affinity constants of EGTA for protons and divalent ions including calcium. Biochim Biophys Acta (1985) 1.65
Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. J Virol (1986) 1.62
Endocrine function after spontaneous infarction of the human pituitary: report, review, and reappraisal. Endocr Rev (1980) 1.58
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J Clin Pathol (1990) 1.57
Calcium-induced calcium release activates contraction in intact cardiac cells. Pflugers Arch (1989) 1.57
The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology (2000) 1.56
Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J Gen Virol (1997) 1.54
Suramin, an active drug for prostate cancer: interim observations in a phase I trial. J Natl Cancer Inst (1993) 1.54
Mutagenesis of cauliflower mosaic virus. Gene (1983) 1.53
Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol (1977) 1.53
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J Gen Virol (2000) 1.52
Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology (1992) 1.50
Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. J Gen Virol (1997) 1.49
The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology (2001) 1.48
The influence of tackle parameters on the propensity for injury in international football. Am J Sports Med (2004) 1.47
Lack of HIV infection and condom use in licensed prostitutes. Lancet (1986) 1.46
Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J Gen Virol (1999) 1.46
Preliminary studies of absorption and excretion of benoxaprofen in man. Br J Clin Pharmacol (1977) 1.46
The arginine provocative test: an aid in the diagnosis of hyposomatotropism. J Clin Endocrinol Metab (1967) 1.45
Replication of the influenza virus genome. Virology (1982) 1.45
Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. Science (1984) 1.42
S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42
The use of bladder for total transplant ureteral reconstruction. J Urol (1998) 1.40
Testicular prosthesis placement: a new technique. BJU Int (1999) 1.40
Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol (1996) 1.39
A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci U S A (1996) 1.39
A viral mechanism for inhibition of the cellular phosphatase calcineurin. Science (1998) 1.39
Influence of traumatic grief on suicidal ideation among young adults. Am J Psychiatry (1999) 1.38
Field evaluation of Haemophilus somnus bacterin. Vet Med Small Anim Clin (1977) 1.38
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol (2000) 1.38
Circumcision as a risk factor for urethritis in racial groups. Am J Public Health (1987) 1.38
The relationship between intracellular calcium and contraction in calcium-overloaded ferret papillary muscles. J Physiol (1985) 1.37
Purified multiplication-stimulating activity from rat liver cell conditioned medium: comparison of biological activities with calf serum, insulin, and somatomedin. J Cell Physiol (1974) 1.37
Molecular epidemiology of African swine fever virus studied by analysis of four variable genome regions. Arch Virol (2006) 1.35
Difficulties encountered in the search for the etiologic agents of destructive periodontal diseases. J Clin Periodontol (1987) 1.35
Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. Virology (1995) 1.34
The PA influenza virus polymerase subunit is a phosphorylated protein. J Gen Virol (1998) 1.33
Antibody neutralization of the extracellular enveloped form of vaccinia virus. Virology (2001) 1.32
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J Gen Virol (1998) 1.32
Simultaneous measurements of action potential duration and intracellular ATP in isolated ferret hearts exposed to cyanide. Circ Res (1989) 1.31
Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity. Mol Cell Biol (1986) 1.31
An evaluation of direct access radiology in general practice. J R Coll Gen Pract (1979) 1.31